{"id":"https://openalex.org/W2883486569","doi":"https://doi.org/10.1016/j.clinthera.2018.05.011","title":"Preventive Effects of Renin-angiotensin System Inhibitors on Oxaliplatin-induced Peripheral Neuropathy: A Retrospective Observational Study","display_name":"Preventive Effects of Renin-angiotensin System Inhibitors on Oxaliplatin-induced Peripheral Neuropathy: A Retrospective Observational Study","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2883486569","doi":"https://doi.org/10.1016/j.clinthera.2018.05.011","mag":"2883486569","pmid":"https://pubmed.ncbi.nlm.nih.gov/29983264"},"language":"en","primary_location":{"id":"doi:10.1016/j.clinthera.2018.05.011","doi":"https://doi.org/10.1016/j.clinthera.2018.05.011","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clinthera.2018.05.011","pdf_url":null,"source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061856367","display_name":"Mami Uchida","orcid":"https://orcid.org/0000-0002-4997-0302","observed_orcids":["https://orcid.org/0000-0002-4997-0302"]},"institutions":[{"id":"https://openalex.org/I36646682","display_name":"Matsuyama University","ror":"https://ror.org/05tc07s46","country_code":"JP","type":"education","lineage":["https://openalex.org/I36646682"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mami Uchida","raw_affiliation_strings":["Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, Japan","institution_ids":["https://openalex.org/I36646682"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hitoshi Kawazoe","orcid":"https://orcid.org/0000-0003-1591-4051","observed_orcids":["https://orcid.org/0000-0003-1591-4051"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]},{"id":"https://openalex.org/I4210110672","display_name":"Ehime University Hospital","ror":"https://ror.org/01vpa9c32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210110672","https://openalex.org/I43545212"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitoshi Kawazoe","raw_affiliation_strings":["Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan; Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, 1-5-30 Shibakoen, Minato-ku, Tokyo, Japan","Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, 1-5-30 Shibakoen, Minato-ku, Tokyo, Japan","Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan"],"raw_orcid":"https://orcid.org/0000-0003-1591-4051","affiliations":[{"raw_affiliation_string":"Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan; Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, 1-5-30 Shibakoen, Minato-ku, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103","https://openalex.org/I4210110672"]},{"raw_affiliation_string":"Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, 1-5-30 Shibakoen, Minato-ku, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103"]},{"raw_affiliation_string":"Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan","institution_ids":["https://openalex.org/I4210110672"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030821701","display_name":"Shingo Takatori","orcid":"https://orcid.org/0000-0002-5498-0564","observed_orcids":["https://orcid.org/0000-0002-5498-0564"]},"institutions":[{"id":"https://openalex.org/I36646682","display_name":"Matsuyama University","ror":"https://ror.org/05tc07s46","country_code":"JP","type":"education","lineage":["https://openalex.org/I36646682"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shingo Takatori","raw_affiliation_strings":["Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, Japan. Electronic address: stakator@g.matsuyama-u.ac.jp","Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, Japan"],"raw_orcid":"https://orcid.org/0000-0002-5498-0564","affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, Japan. Electronic address: stakator@g.matsuyama-u.ac.jp","institution_ids":["https://openalex.org/I36646682"]},{"raw_affiliation_string":"Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, Japan","institution_ids":["https://openalex.org/I36646682"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hiroyuki Namba","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36646682","display_name":"Matsuyama University","ror":"https://ror.org/05tc07s46","country_code":"JP","type":"education","lineage":["https://openalex.org/I36646682"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroyuki Namba","raw_affiliation_strings":["Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, Japan","institution_ids":["https://openalex.org/I36646682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001610890","display_name":"Ryuji Uozumi","orcid":"https://orcid.org/0000-0002-9546-9869","observed_orcids":["https://orcid.org/0000-0002-9546-9869"]},"institutions":[{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryuji Uozumi","raw_affiliation_strings":["Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan"],"raw_orcid":"https://orcid.org/0000-0002-9546-9869","affiliations":[{"raw_affiliation_string":"Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan","institution_ids":["https://openalex.org/I22299242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101409481","display_name":"Akihiro Tanaka","orcid":"https://orcid.org/0000-0001-6306-8166","observed_orcids":["https://orcid.org/0000-0001-6306-8166"]},"institutions":[{"id":"https://openalex.org/I4210110672","display_name":"Ehime University Hospital","ror":"https://ror.org/01vpa9c32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210110672","https://openalex.org/I43545212"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akihiro Tanaka","raw_affiliation_strings":["Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan","institution_ids":["https://openalex.org/I4210110672"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109842907","display_name":"Hiromu Kawasaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36646682","display_name":"Matsuyama University","ror":"https://ror.org/05tc07s46","country_code":"JP","type":"education","lineage":["https://openalex.org/I36646682"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiromu Kawasaki","raw_affiliation_strings":["Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, Japan","institution_ids":["https://openalex.org/I36646682"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112659639","display_name":"Hiroaki Araki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129844524","display_name":"Shujitsu University","ror":"https://ror.org/03mezqr97","country_code":"JP","type":"education","lineage":["https://openalex.org/I129844524"]},{"id":"https://openalex.org/I4210110672","display_name":"Ehime University Hospital","ror":"https://ror.org/01vpa9c32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210110672","https://openalex.org/I43545212"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroaki Araki","raw_affiliation_strings":["Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan; Faculty of Pharmaceutical Sciences, Shujitsu University, 1-6-1 Nishigawara, Naka-ku, Okayama, Japan","Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan","Faculty of Pharmaceutical Sciences, Shujitsu University, 1-6-1 Nishigawara, Naka-ku, Okayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan; Faculty of Pharmaceutical Sciences, Shujitsu University, 1-6-1 Nishigawara, Naka-ku, Okayama, Japan","institution_ids":["https://openalex.org/I129844524","https://openalex.org/I4210110672"]},{"raw_affiliation_string":"Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan","institution_ids":["https://openalex.org/I4210110672"]},{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Shujitsu University, 1-6-1 Nishigawara, Naka-ku, Okayama, Japan","institution_ids":["https://openalex.org/I129844524"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5030821701"],"corresponding_institution_ids":["https://openalex.org/I36646682"],"apc_list":{"value":4240,"currency":"USD","value_usd":4240},"apc_paid":null,"fwci":0.9389,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.76415338,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"40","issue":"7","first_page":"1214","last_page":"1222.e1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.859000027179718},{"id":"https://openalex.org/keywords/peripheral-neuropathy","display_name":"peripheral neuropathy","score":0.9509999752044678},{"id":"https://openalex.org/keywords/renin-angiotensin-system-inhibitors","display_name":"renin-angiotensin system inhibitors","score":0.9879999756813049},{"id":"https://openalex.org/keywords/chemotherapy-induced-neurotoxicity","display_name":"chemotherapy-induced neurotoxicity","score":0.8799999952316284},{"id":"https://openalex.org/keywords/cancer-chemotherapy","display_name":"cancer chemotherapy","score":0.640999972820282},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9458422064781189},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.9071469306945801},{"id":"https://openalex.org/C2777793932","wikidata":"https://www.wikidata.org/wiki/Q1116229","display_name":"Common Terminology Criteria for Adverse Events","level":3,"score":0.6968683004379272},{"id":"https://openalex.org/C2779901536","wikidata":"https://www.wikidata.org/wiki/Q945238","display_name":"Peripheral neuropathy","level":3,"score":0.6923344731330872},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6438634395599365},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6103509664535522},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5512844920158386},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.5361682176589966},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4725969433784485},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.45718854665756226},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4232426881790161},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3770289421081543},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.28673455119132996},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.2696072459220886},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.15498539805412292},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.13319343328475952},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.12858015298843384},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.06106126308441162},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010523","descriptor_name":"Peripheral Nervous System Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D010523","descriptor_name":"Peripheral Nervous System Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020258","descriptor_name":"Neurotoxicity Syndromes","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.clinthera.2018.05.011","doi":"https://doi.org/10.1016/j.clinthera.2018.05.011","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clinthera.2018.05.011","pdf_url":null,"source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},{"id":"pmid:29983264","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29983264","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1051008347","https://openalex.org/W1993780950","https://openalex.org/W1999935086","https://openalex.org/W2002553781","https://openalex.org/W2007771577","https://openalex.org/W2014004239","https://openalex.org/W2036368100","https://openalex.org/W2067638174","https://openalex.org/W2074671977","https://openalex.org/W2084717664","https://openalex.org/W2085705101","https://openalex.org/W2099756738","https://openalex.org/W2103132778","https://openalex.org/W2112092094","https://openalex.org/W2121368761","https://openalex.org/W2143743735","https://openalex.org/W2149603226","https://openalex.org/W2151253787","https://openalex.org/W2158499547","https://openalex.org/W2165982376","https://openalex.org/W2167138718","https://openalex.org/W2170802167","https://openalex.org/W2171232394","https://openalex.org/W2234446037","https://openalex.org/W2591526702","https://openalex.org/W2637410905"],"related_works":["https://openalex.org/W3216967725","https://openalex.org/W4389150916","https://openalex.org/W4281384293","https://openalex.org/W3151237978","https://openalex.org/W3013605775","https://openalex.org/W3186160686","https://openalex.org/W2529715048","https://openalex.org/W7128954182","https://openalex.org/W4283785502","https://openalex.org/W3128326796"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-08-03T00:00:00"}